AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Jun 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-06-19

Reporting Person: Prout Samantha (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-19	Common Stock	M	3366	$10.04	Acquired	20501	Direct
2020-06-19	Common Stock	S	3366	$15.00	Disposed	17135	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-19	Stock Options (right to buy)	$10.04	M	3366	Disposed	2029-01-02	Common Stock (3366)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: As of June 19, 2020, 3,366 options were fully vested and exercisable and 6,138 remained unvested from this grant.